Apposite Capital-backed Kelso Pharma acquires Stirling Anglian Pharmaceuticals
Apposite Capital, the healthcare specialist private equity investor, and Kelso Pharma today announce the acquisition of Stirling Anglian Pharmaceuticals Limited. Kelso Pharma is headed by Dr Tom Stratford, previously CEO of Kyowa Kirin International (“KKI”), the European and US business arm of Kyowa Kirin, which purchased Scottish Borders based ProStrakan Group PLC in 2011. He […]
